Expert Identified Anhedonia as Suicide Predictor

In 2026, psychiatrist Anita Clayton highlighted the role of anhedonia in clinical depression outcomes.

Updated on Oct. 3, 2026 in Mental Health

Bold flat-color editorial illustration of an empty vessel in deep red and cream, representing the absence of pleasure in depression. — Psychiatrist Anita Clayton identified anhedonia, the inability to feel pleasure, as a critical independent predictor for suicide risk in patients. AI Illustration. Upload story photo >

Live Poll

Should doctors routinely screen patients for anhedonia during standard health checkups?

At a 2026 conference in Jersey City, Dr. Anita Clayton presented analysis on anhedonia as a critical indicator for suicide risk and patient relapse. The findings suggest that a loss of pleasure in daily activities can serve as an independent warning sign, even when patients do not report classic sadness.

Why it matters

Understanding anhedonia as an independent symptom is vital because standard monoaminergic antidepressants often fail to address this condition. Recognizing it early can help clinicians prevent incomplete remission and address suicidal ideation more effectively.

The Snaith-Hamilton Pleasure Scale utilizes 14 distinct items to measure interest, while clinical trials typically employ a 4-point rating scale to track patient responses. These tools assist clinicians who currently rely on the PHQ-9 and GAD-7 questionnaires for routine practice.

The players

Anita Clayton

She is a professor at the University of Virginia who specializes in the study and treatment of mood disorders.

The details

Anhedonia, defined as the inability to feel pleasure, remains a core feature of depression that can occur in patients who deny feeling sad. Dr. Clayton noted that patients complete standard questionnaires independently, but the persistence of anhedonia marks a distinct challenge for treatment plans.

Dr. Anita Clayton discussed anhedonia at the Jersey City conference in 2026.

The Big Picture

This research suggests a limitation in relying solely on the PHQ-9 depression screening questionnaire by identifying anhedonia as a distinct, independent predictor of suicidal ideation.

Patients may find that their healthcare providers begin using more specialized tools to screen for pleasure loss rather than just sadness. This change could lead to more tailored treatment approaches when standard antidepressants do not alleviate symptoms of listlessness.

The takeaway

Recognizing that a lack of interest in hobbies is a medical symptom rather than a personal character flaw can be a vital step for those struggling with depression. Patients are encouraged to communicate specific feelings of numbness to their doctors, even if they do not experience deep sadness.